Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer
2090.6000 -2.00 (-0.10%)
NSE Dec 16, 2025 15:31 PM
Volume: 604.2K
 

logo
Lupin Ltd.
14 Jun 2021
2090.60
-0.10%
Lupin gets UK nod to launch generic asthma inhaler drug Fostair
Lupin gets UK nod to launch generic asthma inhaler drug Fostair
Moneycontrol
Respiratory diseases affect one in five people. It is the third biggest cause of death in the UK and is a clinical priority for the NHS.
Number of FII/FPI investors decreased from 987 to 970 in Sep 2025 qtr
USFDA warning letter to Lupin's US facility
Business Line | 14 Jun 2021 6 more
More from Lupin Ltd.
Recommended
Five stocks to buy from analysts this week - December 16, 2025
The Baseline | 16 Dec 2025, 06:03PM
Market closes lower as the rupee hits an all-time low
Trendlyne Marketwatch | 16 Dec 2025, 03:57PM
Lupin expects normalization by September quarter
| 17 Apr 2020